Short-term heart rate variability in healthy dogs and dogs in various stages of degenerative mitral valve disease evaluated before pharmacotherapy

2021 ◽  
pp. 105704
Author(s):  
R.A. Baisan ◽  
V. Vulpe ◽  
D.G. Ohad
Keyword(s):  
Heart Rate ◽  
Heart Rate Variability ◽  
Mitral Valve ◽  
Mitral Valve Disease ◽  
Valve Disease ◽  
Short Term ◽  
Healthy Dogs

Short-term heart rate variability in dogs with sick sinus syndrome or chronic mitral valve disease as compared to healthy controls

2017 ◽  
Vol 20 (1) ◽  
pp. 167-172 ◽  
Author(s):  
Sz. Bogucki ◽  
A. Noszczyk-Nowak
Keyword(s):  
Heart Rate ◽  
Heart Rate Variability ◽  
Standard Deviation ◽  
Mitral Valve ◽  
Mitral Valve Disease ◽  
Sick Sinus Syndrome ◽  
Study Groups ◽  
Valve Disease ◽  
Healthy Controls ◽  
Short Term

Abstract Heart rate variability is an established risk factor for mortality in both healthy dogs and animals with heart failure. The aim of this study was to compare short-term heart rate variability (ST-HRV) parameters from 60-min electrocardiograms in dogs with sick sinus syndrome (SSS, n=20) or chronic mitral valve disease (CMVD, n=20) and healthy controls (n=50), and to verify the clinical application of ST-HRV analysis. The study groups differed significantly in terms of both time - and frequency- domain ST-HRV parameters. In the case of dogs with SSS and healthy controls, particularly evident differences pertained to HRV parameters linked directly to the variability of R-R intervals. Lower values of standard deviation of all R-R intervals (SDNN), standard deviation of the averaged R-R intervals for all 5-min segments (SDANN), mean of the standard deviations of all R-R intervals for all 5-min segments (SDNNI) and percentage of successive R-R intervals >50 ms (pNN50) corresponded to a decrease in parasympathetic regulation of heart rate in dogs with CMVD. These findings imply that ST-HRV may be useful for the identification of dogs with SSS and for detection of dysautonomia in animals with CMVD.

Heart Rate, Heart Rate Variability, and Arrhythmias in Dogs with Myxomatous Mitral Valve Disease

2011 ◽  
Vol 26 (1) ◽  
pp. 76-84 ◽  
Author(s):  
C.E. Rasmussen ◽  
T. Falk ◽  
N.E. Zois ◽  
S.G. Moesgaard ◽  
J. Häggström ◽  
...  
Keyword(s):  
Heart Rate ◽  
Heart Rate Variability ◽  
Mitral Valve ◽  
Mitral Valve Disease ◽  
Valve Disease

scholarly journals Heart rate variability and arrhythmias evaluated with Holter in dogs with degenerative mitral valve disease

2014 ◽  
Vol 66 (2) ◽  
pp. 425-432 ◽  
Author(s):  
M.S. Oliveira ◽  
R.A.L. Muzzi ◽  
R.B. Araújo ◽  
L.A.L. Muzzi ◽  
D.F. Ferreira ◽  
...  
Keyword(s):  
Heart Failure ◽  
Heart Rate ◽  
Heart Rate Variability ◽  
Mitral Valve ◽  
Mitral Valve Disease ◽  
Heart Rhythm ◽  
Valve Disease ◽  
Total Power ◽  
High Heart Rate ◽  
Parasympathetic Control

Cardiac diseases promote alterations in the autonomic control of the heart, leading to an increase in heart rate and, as a result, a decrease in heart rate variability (HRV).The aim of this study was to evaluate if the development of heart failure secondary to degenerative mitral valve disease (DMVD) concurs with changes in autonomic modulation of heart rhythm which are assessed by long electrocardiography examination (Holter). Dogs were evaluated by clinical examination and echocardiography in order to be categorized into the following groups: Control (healthy; n=6), DMVD (disease without heart failure; n=8), and DMVD heart failure (disease with heart failure; n=13). Arrhythmias and frequency domain HRV were determined by Holter. Diseased animals, when compared to healthy, had significantly lower total power, which indicates overall HRV. DMVD heart failure dogs also showed other disturbances such as high incidence of supraventricular arrhythmias, high heart rate, little amount of pauses (2.0s long between consecutive heartbeats), longer time in tachycardia, shorter time in bradycardia, low high frequency (parasympathetic control), and high low frequency (sympathetic and parasympathetic control) when compared to control (p<0.05). In DMVD dogs, Holter-derived variables changed with the development of heart failure.

Heart rate variability parameters of myxomatous mitral valve disease in dogs with and without heart failure obtained using 24-hour Holter electrocardiography

2012 ◽  
Vol 170 (24) ◽  
pp. 622-622 ◽  
Author(s):  
M. S. Oliveira ◽  
R. A. L. Muzzi ◽  
R. B. Araújo ◽  
L. A. L. Muzzi ◽  
D. F. Ferreira ◽  
...  
Keyword(s):  
Heart Failure ◽  
Heart Rate ◽  
Heart Rate Variability ◽  
Mitral Valve ◽  
Mitral Valve Disease ◽  
Valve Disease

scholarly journals Heart rate variability and quality of life in dogs with mitral valve disease treated with metoprolol

2021 ◽  
Vol 43 ◽  
pp. e003020
Author(s):  
Tamyris Beluque ◽  
Aparecido Antonio Camacho ◽  
Roberto Navarrete Ampuero ◽  
Jaislane Bastos Braz ◽  
Murillo Daparé Kirnew ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Heart Rate ◽  
Heart Rate Variability ◽  
Mitral Valve ◽  
Mitral Valve Disease ◽  
Valve Disease

scholarly journals Dietary intervention reduces left atrial enlargement in dogs with early preclinical myxomatous mitral valve disease: a blinded randomized controlled study in 36 dogs

2019 ◽  
Vol 15 (1) ◽  
Author(s):  
Qinghong Li ◽  
Allison Heaney ◽  
Natalie Langenfeld-McCoy ◽  
Brittany Vester Boler ◽  
Dorothy P. Laflamme
Keyword(s):  
Mitral Valve ◽  
Mitral Valve Disease ◽  
Left Atrial ◽  
Alternative Energy ◽  
Dietary Intervention ◽  
Valve Disease ◽  
Controlled Study ◽  
Cardiac Health ◽  
Healthy Dogs ◽  
Energy Deprivation

Abstract Background Myxomatous mitral valve disease (MMVD), the most common naturally-occurring heart disease in dogs, is associated with alterations in energy metabolism, oxidative stress and inflammation. Energy deprivation plays a causal role in the development of heart failure. This study was designed to determine if a cardiac protection blend (CPB) of nutrients containing medium-chain triglycerides as an alternative energy source, fish oil to reduce inflammation, antioxidants, and other key nutrients important to cardiac health and function could slow or prevent MMVD progression. Nineteen dogs with early stage MMVD and 17 breed-, age-, and sex-matched healthy dogs were enrolled for a 6-month blinded, placebo-controlled study. Dogs in each cardiac health group were randomly assigned to either control diet (CON) or CPB-supplemented diet. Echocardiography was performed at baseline, 3 months and 6 months. Results No changes were found in healthy dogs. While MMVD-CON dogs had an average 10% increase over baseline in left atrial diameter (LAD) and left atrial to aortic root ratio (LA/Ao) at 6 months, MMVD-CPB dogs showed 3% decreases, resulting significant diet by time interactions (P = 0.037, P = 0.005, respectively). More MMVD-CON dogs progressed from stage B1 to B2 during the study. A positive correlation was found between 6-month changes in LAD and blood pressures in MMVD-CPB dogs (systolic: P = 0.050, diastolic: P = 0.035) but not MMVD-CON dogs. Conclusions Our results demonstrated efficacy of CPB-based dietary intervention in reducing LA size and mitral regurgitation, and in slowing or preventing the progression of early MMVD in dogs.

scholarly journals Evaluation of the functional capacity in dogs with naturally acquired heart disease

2013 ◽  
Vol 58 (No. 5) ◽  
pp. 264-270 ◽  
Author(s):  
CF Agudelo ◽  
P. Schanilec
Keyword(s):  
Heart Disease ◽  
Mitral Valve ◽  
Functional Capacity ◽  
Mitral Valve Disease ◽  
Maximal Exercise ◽  
Valve Disease ◽  
Exercise Tests ◽  
Walking Test ◽  
Acquired Heart Disease ◽  
Healthy Dogs

Functional capacity is the physical ability to perform a defined task. In humans it can be evaluated by using exercise testing, for instance sub-maximal exercise tests. Walking tests are widely used variations of sub-maximal exercise tests and in human medicine are considered to be realistically related to daily physical activity and prognosis in patients with heart failure. The aim of this study was to assess a sub-maximal exercise test in dogs with varying degrees of heart disease. The 6-minute walking test was used to test the functional capacity in healthy dogs and dogs with heart disease (degenerative mitral valve disease). Three groups of untrained owned dogs were compared. Two groups were dogs had mild and moderate degenerative mitral valve disease (ME-1 and ME-2, respectively) and the third group comprised healthy dogs with the same age and size conditions. Both groups of dogs with mitral valve disease walked shorter distances during 6 min (control 448.92 m; ME-1: 406.89 m; ME-2: 350.04 m). The influence of the test on the heart rate, electrocardiography and blood pressure was also evaluated. Although the 6-minute walking test has already been tested in healthy dogs, dogs with chronic pulmonary disease and dogs with artificially induced heart disease, this is the first time that this test has been validated in elderly dogs with naturally acquired heart disease. Thus, we demonstrate here that this test can be used reliably for assessing functional capacity in dogs with heart disease. &nbsp;

scholarly journals Transcriptomic profiling of peripheral blood nucleated cells in dogs with and without clinical signs of chronic mitral valve disease

2014 ◽  
Vol 58 (1) ◽  
pp. 135-140
Author(s):  
Magdalena Garncarz ◽  
Magdalena Hulanicka ◽  
Marta Parzeniecka-Jaworska ◽  
Jacek Garncarz ◽  
Michał Jank
Keyword(s):  
Gene Expression ◽  
Heart Failure ◽  
Mitral Valve ◽  
Peripheral Blood ◽  
Mitral Valve Disease ◽  
Clinical Signs ◽  
Valve Disease ◽  
Non Invasive ◽  
The Status ◽  
Healthy Dogs

Abstract The aim of the study was to demonstrate differences in the gene expression of signalling pathways between healthy dogs and dogs with chronic mitral valve disease in different heart failure groups. Blood samples were collected from 49 dogs of various breeds between 1.4 and 15.2 years of age. Isolated RNA samples were analysed for quality and integrity and the gene expression profile was determined. The study demonstrated that nucleated cells from peripheral blood can be used to assess the status of heart failure in dogs. Furthermore, significant differences in the expression of the genes were noticed between healthy dogs and dogs with clinical signs of chronic mitral valve disease. This is a preliminary non-invasive study showing the feasibility of genetic testing from peripheral blood nucleated cells, which at the same time has made it possible to set the future directions of genetic studies in clinical cases of canine chronic mitral valve disease.

Short-term heart rate variability (HRV) in healthy dogs

2015 ◽  
Vol 18 (2) ◽  
pp. 307-312 ◽  
Author(s):  
Sz. Bogucki ◽  
A. Noszczyk-Nowak
Keyword(s):  
Heart Rate ◽  
Heart Rate Variability ◽  
Reference Values ◽  
Low Frequency ◽  
Total Power ◽  
Short Term ◽  
Ventricular Premature Complexes ◽  
Healthy Dogs ◽  
Hrv Analysis ◽  
Fixed Times

AbstractHeart rate variability (HRV) is a well established mortality risk factor in both healthy dogs and those with heart failure. While the standards for short-term HRV analysis have been developed in humans, only reference values for HRV parameters determined from 24-hour ECG have been proposed in dogs. The aim of this study was to develop the reference values for short-term HRV parameters in a group of 50 healthy dogs of various breeds (age 4.86 ± 2.74 years, body weight 12.2 ± 3.88 kg). The ECG was recorded continuously for at least 180 min in a dark and quiet room. All electrocardiograms were inspected automatically and manually to eliminate atrial or ventricular premature complexes. Signals were transformed into a spectrum using the fast Fourier transform. The HRV parameters were measured at fixed times from 60-min ECG segments. The following time-domain parameters (ms) were analyzed: mean NN, SDNN, SDANN, SDNN index, rMSSD and pNN50. Moreover, frequency-domain parameters (Hz) were determined, including very low frequency (VLF), low frequency (LF) and high frequency (HF) components, total power (TP) and the LF/HF ratio. The results (means ± SD) were as follows: mean NN = 677.68 ± 126.89; SDNN = 208.86 ± 77.1; SDANN = 70.75 ± 30.9; SDNN index = 190.75 ± 76.12; rMSSD = 259 ± 120.17, pNN50 = 71.84 ± 13.96; VLF = 984.96 ± 327.7; LF = 1501.24 ± 736.32; HF = 5845.45 ± 2914.20; TP = 11065.31 ± 3866.87; LF/HF = 0.28 ± 0.11.

Sign in / Sign up

Export Citation Format

Share Document